Number of the records: 1
Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-[gamma] dependent pathway
- 1.
SYSNO ASEP 0307862 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-[gamma] dependent pathway Title Telmisartan zvyšuje oxidaci mastných kyselin ve svalech prostřednictvím aktivace PPARgama Author(s) Sugimoto, K. (JP)
Kazdová, L. (CZ)
Qi, N.R. (US)
Hyakukoku, M. (JP)
Křen, Vladimír (FGU-C)
Šimáková, Miroslava (FGU-C) RID, ORCID
Zídek, Václav (FGU-C) RID
Kurtz, T. W. (US)
Pravenec, Michal (FGU-C) RID, ORCIDSource Title Journal of Hypertension. - : Lippincott Williams & Wilkins - ISSN 0263-6352
Roč. 26, č. 6 (2008), s. 1209-1215Number of pages 7 s. Language eng - English Country GB - United Kingdom Keywords telmisartan ; fatty acid oxidation ; PPARgamma Subject RIV FB - Endocrinology, Diabetology, Metabolism, Nutrition R&D Projects 1M0520 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) NR8495 GA MZd - Ministry of Health (MZ) NR9359 GA MZd - Ministry of Health (MZ) GA301/06/0028 GA ČR - Czech Science Foundation (CSF) Next source Framework programmes of European CommissionNon-public resources CEZ AV0Z50110509 - FGU-C (2005-2011) UT WOS 000256229800021 Annotation Telmisartan increases energy expenditure and protects against dietary induced obesity and features of the metabolic syndrome at least in part by increasing muscle fatty acid oxidation through activation of PPARgamma Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2008
Number of the records: 1